Legend Biotech Corporation (NASDAQ:LEGN) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On ...
Across the recent three months, 9 analysts have shared their insights on Legend Biotech (NASDAQ:LEGN), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...
Legend Biotech (NASDAQ:LEGN) is one of the most promising mid-cap healthcare stocks under $50. As of December 19 closing, the consensus ratings for Legend Biotech (NASDAQ:LEGN) remain bullish. After a ...
Analyst Kostas Biliouris of BMO Capital maintained a Buy rating on Legend Biotech (LEGN – Research Report), retaining the price target of $90.00. Pick the best stocks and maximize your portfolio: ...
Legend Biotech (NASDAQ:LEGN) will release its quarterly earnings report on Wednesday, 2025-11-12. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Legend Biotech to ...
Analysts' ratings for Legend Biotech (NASDAQ:LEGN) over the last quarter vary from bullish to bearish, as provided by 5 analysts. The following table encapsulates their recent ratings, offering a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback